Evaluation of the efficacy and surgical-related safety of neoadjuvant immunochemotherapy in advanced resectable none small cell lung cancer (NSCLC)

Evaluation of the efficacy and surgical-related safety of neoadjuvant immunochemotherapy in advanced resectable none small cell lung cancer (NSCLC)

BackgroundThe emergence of immune checkpoint inhibitors (ICIs) has brought about a paradigm shift in the treatment landscape of non-small cell lung cancer (NSCLC). Despite the promising long-term survival outcomes and optimization of pathological complete response (cPR) demonstrated by various studi...

Full description

Bibliographic Details
Main Authors: Qin Wang, Chen Qi, Jing Luo, Nan Xu, Mao-tian Xu, Yong Qiang, Chi Zhang, Yi Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
neoadjuvant therapy
neoadjuvant immunotherapy
neoadjuvant immunochemotherapy
surgical-related safety
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1239451/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1239451/full

Similar Items